Results 21 to 30 of about 36,566 (267)

Significance of seizure in cerebral venous sinus thrombosis [PDF]

Seizure, 2012
To report the frequency and predictors of presenting seizures in cerebral venous sinus thrombosis (CVST) and their influence on seizure recurrence and outcome.This retrospective study, between 1995 and 2011, included 90 consecutive patients with CVST diagnosed using magnetic resonance imaging (MRI) and magnetic resonance venography (MRV).
Jayantee Kalita, Satish Chandra, U. K. Misra   +2 more
openalex   +4 more sources

Cerebral venous sinus thrombosis in pregnancy and puerperium: A comprehensive review

Brain Circulation, 2022
Cerebral venous sinus thrombosis (CVST) is a distinct neurological emergency caused by occlusion, either partial or complete, of the dural venous sinus and/or the cerebral veins.
H. Algahtani, Abdulrahman S. Bazaid, B. Shirah, Raghad N Bouges   +3 more
semanticscholar   +1 more source

ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST)

BMJ Case Reports, 2021
A 27-year-old fit and well man presented with intermittent headaches associated with eye floaters and vomiting. His symptoms started 48 hours after having the first dose of ChADOx1 nCOV-19 vaccine (Vaxzevria, previously AstraZeneca COVID-19 vaccine ...
P. Suresh, W. Petchey
semanticscholar   +1 more source

Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder

Journal of Neurology Neurosurgery & Psychiatry, 2021
Butler M, et al. J Neurol Neurosurg Psychiatry 2021;0:1–8. doi:10.1136/jnnp-2021-326924 Considerations for causality assessment of neurological and neuropsychiatric complications of SARSCoV-2 vaccines: from cerebral venous sinus thrombosis to functional ...
M. Butler, A. Tamborska, G. Wood, M. Ellul, R. Thomas, I. Galea, S. Pett, Bhagteshwar Singh, T. Solomon, T. Pollak, B. Michael, T. Nicholson   +11 more
semanticscholar   +1 more source

Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19

European Journal of Case Reports in Internal Medicine, 2020
Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the case of a 59-year-old man who presented with headache, hypertension and a single episode of fever with no other symptoms.
C. Hughes, T. Nichols, Martin Pike, C. Subbe, Salah Elghenzai   +4 more
semanticscholar   +1 more source

Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS‐CoV‐2 vaccination

European Journal of Neurology, 2021
High mortality rates have been reported in patients with cerebral venous sinus thrombosis (CVST) due to vaccine‐induced immune thrombotic thrombocytopenia (VITT) after vaccination with adenoviral vector SARS‐CoV‐2 vaccines.
A. van de Munckhof, K. Krzywicka, D. Aguiar de Sousa, M. Sánchez van Kammen, M. Heldner, K. Jood, E. Lindgren, T. Tatlisumak, J. Putaala, J. K. Kremer Hovinga, S. Middeldorp, M. Levi, M. Arnold, J. Ferro, J. Coutinho   +14 more
semanticscholar   +1 more source

Cerebral Venous Sinus (Sinovenous) Thrombosis in Children

Neurosurgery Clinics of North America, 2010
Cerebral venous sinus (sinovenous) thrombosis (CSVT) in childhood is a rare, but underrecognized, disorder, typically of multifactorial etiology, with neurologic sequelae apparent in up to 40% of survivors and mortality approaching 10%. There is an expanding spectrum of perinatal brain injury associated with neonatal CSVT.
Nomazulu Dlamini, Lori Billinghurst, Fenella J. Kirkham   +2 more
openalex   +5 more sources

Cerebral venous sinus thrombosis [PDF]

Postgraduate Medical Journal, 2000
Summary Cerebral venous sinus thrombosis is a challenging condition because of its variability of clinical symptoms and signs. It is very often unrecognised at initial presentation. All age groups can be affected. Large sinuses such as the superior sagittal sinus are most frequently involved.
Holger Allroggen, Richard J Abbott
openaire   +3 more sources

Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.

Journal of the American Medical Association (JAMA), 2021
Importance Cases of cerebral venous sinus thrombosis in combination with thrombocytopenia have recently been reported within 4 to 28 days of vaccination with the ChAdOx1 nCov-19 (AstraZeneca/Oxford) and Ad.26.COV2.S (Janssen/Johnson & Johnson) COVID-19 ...
M. Sánchez van Kammen, M. Heldner, J. Brodard, A. Scutelnic, S. Silvis, V. Schroeder, J. K. Kremer Hovinga, S. Middeldorp, M. Levi, S. Hiltunen, E. Lindgren, M. Mansour, A. Arauz, M. Barboza, S. Zuurbier, D. Aguiar de Sousa, J. Ferro, U. Fischer, Thalia Shoshana Field, K. Jood, T. Tatlisumak, J. Putaala, M. Arnold, J. Coutinho   +23 more
semanticscholar   +1 more source

Efficacy of Stent Thrombectomy Alone or Combined With Intermediate Catheter Aspiration for Severe Cerebral Venous Sinus Thrombosis: A Case-Series

Frontiers in Neurology, 2022
ObjectiveTo assess the safety and efficacy of stent thrombectomy alone or combined with intermediate catheter aspiration for severe cerebral venous sinus thrombosis.MethodWe retrospectively collected the clinical data of 7 patients with severe CVST who ...
Tao Peng, Bitang Dan, Zini Zhang, Bifeng Zhu, Jianlin Liu   +4 more
doaj   +1 more source